Education Materials

Mount Sinai Hospital is a University of Toronto patient care, teaching, and research centre.
Mount Sinai Hospital is a University of Toronto patient care, teaching, and research centre.


November 2004 CBSN Newsletter Reference List

  1. Chen D, McGeer A, de Azavedo JC, Low DE, The Canadian Bacterial Surveillance Network. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Eng J Med 1999;341:233-9.
  2. Davidson R, Cavalcanti R, Brunton JL, Bast DJ, de Azavedo JC, Kibsey P et al. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med 2002;346:747-50.
  3. Bast DJ, Low DE, Duncan CL, Kilburn L, Mandell LA, Davidson RJ, de Azavedo JC. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance. Antimicrob Agents Chemother 2000;44:3049-54.
  4. Bast DJ, de Azavedo JC, Tam TY, Kilburn L, Duncan C, Mandell LA et al. Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 2001;45:2631-4.
  5. Bast DJ, Yue M, Chen X, Bell D, Dresser L, Saskin R et al. Novel murine model of pneumococcal pneumonia: use of temperature as a measure of disease severity to compare the efficacies of moxifloxacin and levofloxacin. Antimicrob Agents Chemother 2004;48:3343-8.
  6. Lim S, Bast D, McGeer A, de AJ, Low DE. Antimicrobial susceptibility breakpoints and first-step parC mutations in Streptococcus pneumoniae: redefining fluoroquinolone resistance. Emerg Infect Dis 2003;9:833-7.
  7. Weiss K, Restieri C, Laverdiere M, McGeer A, Davidson RJ, Kilburn L et al. A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae. Clin Inf Dis 2001;33:517-22.
  8. Powis J, McGeer A, Green K, Vanderkooi O, Weiss K, Zhanel G et al. In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002. Antimicrob Agents Chemother 2004;48:3305-11.
  9. Low DE. Quinolone resistance and its clinical relevance. In: Hooper DC, Rubinstein E, eds. Quinolone Antimicrobial Agents. Washington: American Society for Microbiology Press, 2003:355-86.
  10. Anderson KB, Tan JS, File TM, Jr., DiPersio JR, Willey BM, Low DE. Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia. Clin Infect Dis 2003;37:376-81.
  11. Low DE. Trends and significance of antimicrobial resistance in respiratory pathogens. Curr Opin Infect Dis 2000;13:145-53.
  12. Low DE, de Azavedo J, Weiss CA, Mazzulli T, Kuhn M, Church D et al. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000. Antimicrob Agents Chemother 2002;46:1295-301.
  13. Marrie TJ, Low DE, De CE. A comparison of bacteremic pneumococcal pneumonia with nonbacteremic community-acquired pneumonia of any etiology--results from a Canadian multicentre study. Can Respir J 2003;10:368-74.
  14. Weiss K, de AJ, Restieri C, Quach C, Laverdiere M, Rubin E et al. In vitro activity of a novel ketolide ABT-773 against invasive strains of Streptococcus pneumoniae. J Antimicrob Chemother 2001;48:407-9.
  15. Low DE. Antimicrobial drug use and resistance among respiratory pathogens in the community. Clin Infect Dis 2001;33 Suppl 3:S206-S213.
  16. Richardson DC, Bast D, McGeer A, Low DE. Evaluation of susceptibility testing to detect fluoroquinolone resistance mechanisms in Streptococcus pneumoniae. Antimicrob Agents Chemother 2001;45:1911-4.
  17. Johnston NJ, de Azavedo JC, Kellner JD, Low DE. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 1998;42:2425-6.
  18. Simor AE, Louie M, Low DE. Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance Network. Antimicrob Agents Chemother 1996;40:2190-3.
  19. Skulnick M, Small GW, Lo P, Patel MP, Porter RC, Low DE et al. Evaluation of the accuracy and reproducibility of E test for susceptibility of Streptococcus pneumoniae to penicillin, cefotaxime and ceftriaxone. J Clin Microbiol 1995;33:2334-7.
  20. Allen UD, Thomas S, Carapetis J, Henry S, Wasfy S, Lovgren M et al. Serotypes of respiratory tract isolates of Streptococcus pneumoniae from Jamaican children. Int J Infect Dis 2003;7:29-35.
  21. McGeer A, Low DE. Is resistance futile? Nat Med 2003;9:390-2.

This website has been made possible through an unrestricted educational grant from Pfizer Canada Inc.
Valid HTML 4.0!
©Copyright 1999 Microbiology Department, Mount Sinai Hospital, Toronto, ON, Canada.
All rights reserved. Last Modified